title: Does cilengitide deserve another chance?
authors.affiliation: Department of Biomedical Sciences and Clinical Oncology, University of Bari 'Aldo Moro', 11-70124 Bari, Italy. Electronic address: marco.tucci@uniba.it.
authors.forename: Marco
authors.initials: M
authors.lastname: Tucci
authors.affiliation: Department of Biomedical Sciences and Clinical Oncology, University of Bari 'Aldo Moro', 11-70124 Bari, Italy.
authors.forename: Stefania
authors.initials: S
authors.lastname: Stucci
authors.affiliation: Department of Biomedical Sciences and Clinical Oncology, University of Bari 'Aldo Moro', 11-70124 Bari, Italy.
authors.forename: Franco
authors.initials: F
authors.lastname: Silvestris
mesh_terms: D001932:Brain Neoplasms / Q000188:drug therapy*; D015254:DNA Modification Methylases / Q000235:genetics*; D045643:DNA Repair Enzymes / Q000235:genetics*; D003606:Dacarbazine / Q000031:analogs & derivatives*; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy*; D006801:Humans; D008297:Male; D012910:Snake Venoms / Q000627:therapeutic use*; D025521:Tumor Suppressor Proteins / Q000235:genetics*
chemical_list: D012910:Snake Venoms; D025521:Tumor Suppressor Proteins; D003606:Dacarbazine; D015254:DNA Modification Methylases; D045643:DNA Repair Enzymes